2,5-bis[4-(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents

Journal of Medicinal Chemistry
David W BoykinR R Tidwell

Abstract

The syntheses of 12 new 2,5-bis[4-(N-alkylamidino)phenyl]furans are reported. The interaction of these dicationic furans with poly(dA-dT) and with the duplex oligomer d(CGCGAATTCGCG)2 was determined by Tm measurements, and the effectiveness of these compounds against the immunosuppressed rat model of Pneumocystis carinii was evaluated. At the screening dose of 10 mumol/kg, 9 of the 14 N-alkylamidino furans described here are more active than the parent compound 1. Substitution of an alkyl group of the amidino nitrogen, except for in 9, 13, and 15, resulted in higher affinity for DNA than the parent compound as judged by the larger delta Tm values and suggests enhanced van der Waals interactions in the bis-amidine-DNA complex. Five of the compounds, 3, 5, 7, 10, and 12, yield cyst counts of less than 0.1% of control when administered at a dosage of 10 mumol/kg. Five compounds, 1, 6, 8, 10, and 12, show significant activity at a dosage of approximately 1 mumol/kg; 12 is the most active derivative, and it is approximately 100 times more effective than pentamidine in this animal model.

References

Jun 1, 1995·Nature Medicine·D Henderson, L H Hurley
Apr 1, 1994·Journal of Biomolecular Structure & Dynamics·F A TaniousW D Wilson
Jul 6, 1993·Biochemistry·K JansenB Nordén
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·J E CouryL A Bottomley
Jan 1, 1994·European Journal of Medicinal Chemistry·J SpychalaRf Schinazi
Jan 1, 1996·European Journal of Medicinal Chemistry·A KumarR Tidwell

❮ Previous
Next ❯

Citations

Jun 14, 2002·Archives of Biochemistry and Biophysics·Ihtshamul Haq
Dec 29, 2000·Bioorganic & Medicinal Chemistry Letters·I J SimpsonS Neidle
Oct 10, 2001·Bioorganic & Medicinal Chemistry Letters·T L HuangI O Donkor
Jun 5, 2003·Bioorganic & Medicinal Chemistry Letters·Chad E StephensDavid W Boykin
Dec 28, 1999·Bioorganic & Medicinal Chemistry Letters·A L Satz, T C Bruice
Jan 11, 2013·Journal of Medicinal Chemistry·Caitriona McKeeverIsabel Rozas
Sep 3, 1999·The Journal of Antimicrobial Chemotherapy·M Del PoetaJ R Perfect
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·James J BrendleKarl A Werbovetz
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Andrea L CrowellW Evan Secor
Aug 5, 2011·PloS One·Denise da Gama Jaén BatistaMaria de Nazaré Correia Soeiro
Jul 30, 2005·Expert Opinion on Investigational Drugs·M N C SoeiroD W Boykin
Mar 18, 2008·Biochimie·W David WilsonDavid W Boykin
Jan 30, 2004·Biophysical Journal·Binh NguyenW David Wilson
Jun 30, 2000·Journal of Molecular Biology·S MazurW D Wilson
Jun 28, 2005·Bioorganic & Medicinal Chemistry Letters·Gour Hari JanaNeelima Sinha
Oct 11, 2011·ChemMedChem·Joscha KotthausBernd Clement
Aug 11, 2012·Journal of Biomolecular Structure & Dynamics·Hemant Kumar Srivastava, G Narahari Sastry
Feb 6, 2002·Chembiochem : a European Journal of Chemical Biology·P BilikC Bailly
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·M Del PoetaJ R Perfect
Nov 16, 2016·Bioorganic & Medicinal Chemistry Letters·Abdelbasset A FarahatDavid W Boykin
Jun 23, 1999·Journal of Medicinal Chemistry·I FrancesconiD W Boykin
Mar 10, 2009·Journal of Medicinal Chemistry·Svetlana M BakunovaRichard R Tidwell
Oct 17, 2003·Journal of Medicinal Chemistry·Mohamed A IsmailDavid W Boykin
Oct 29, 2004·Journal of Medicinal Chemistry·Jonathan B ChairesW David Wilson
Aug 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Livio RacanéMarijana Hranjec
Aug 18, 2006·Journal of Medicinal Chemistry·Mohamed A IsmailDavid W Boykin
Jun 25, 2004·Journal of Medicinal Chemistry·Mohamed A IsmailDavid W Boykin
Sep 28, 1998·Journal of Medicinal Chemistry·K T HopkinsD W Boykin
Mar 7, 2003·Journal of Medicinal Chemistry·Isaac O DonkorCyrus Bacchi
Jun 15, 2007·Journal of the American Chemical Society·Benjamin E BrooksRichard G Brennan
May 18, 2001·Journal of Medicinal Chemistry·C E StephensD W Boykin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.